NATALIE GERZANICH: Open Payments
NPI 1568911923 · NORTH MIAMI BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,510 in 54 payments from 20 companies in 2025. Trend: 2023 $281 · 2024 $1,176 · 2025 $1,510
Food & beverage: $1,343Education: $167
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $238 |
| AstraZeneca Pharmaceuticals LP | 4 | $181 |
| SEAGEN INC. | 2 | $167 |
| GlaxoSmithKline, LLC. | 2 | $140 |
| TerSera Therapeutics LLC | 10 | $139 |
| Rigel Pharmaceuticals, Inc. | 1 | $123 |
| Daiichi Sankyo Inc. | 5 | $104 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| Janssen Biotech, Inc. | 2 | $47 |
| Incyte Corporation | 2 | $45 |
Products named: Enhertu, Zoladex, TAVALISSE, OJJAARA, ELREXFIO, TIVDAK, KISQALI, VERZENIO.
Industry payments across FL — which companies pay providers there.
